Continued Ventilation During Cardiopulmonary Bypass
- Conditions
- Coronary Artery Disease
- Interventions
- Other: Non-ventilated GroupOther: Lung Ventilation
- Registration Number
- NCT01627756
- Lead Sponsor
- Medical University of Vienna
- Brief Summary
Cardiopulmonary bypass (CPB) is well known to induce a strong anti-inflammatory response. The investigators examined whether continued mechanical ventilation during CPB alters systemic immune activation.
- Detailed Description
Cardiopulmonary bypass is well known to induce a strong anti-inflammatory response. Studies had been shown that the contact of blood components with artificial surfaces, the surgical trauma, endotoxemia and a reperfusion injury are in part responsible for the seen immunological affect after surgery. The purpose of this study is to test the effect of continued mechanical ventilation during surgery on a blood marker called soluble ST2 in patients sera. Soluble ST2 acts as a decoy receptor of IL-33 and has anti-inflammatory effects. Elevated soluble ST2 concentrations are reported in patients with acute myocardial infarction, sepsis, congestive heart failure and elevates soluble ST2 levels are associated with adverse outcome.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- Written informed consent
- age > 40 and < 80
- treatment with steroids or immunomodulatory interventions during the past four weeks
- signs of an acute infection
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Non-ventilation Group Non-ventilated Group In the non-ventilated group lungs were collapsed after completion of CPB until after weaning from the extracorporeal circulation. Ventilation Group Lung Ventilation Volume controlled ventilation was done during the whole surgery.
- Primary Outcome Measures
Name Time Method Alteration of soluble ST2 concentration in serum Preoperative, postoperative, day 1, day 2, day 3, day 4, day 5 after surgery Concentration of soluble ST2 will be assessed in the serum of patient´s preoperativem, postoperative and the following five consecutive days after surgery.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Medical University of Debrecen
🇭🇺Debrecen, Hungary